Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FESOTERODINE FUMARATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for FESOTERODINE FUMARATE EXTENDED-RELEASE TABLETS. FESOTERODINE FUMARATE extended-release tablets, for oral use Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Fesoterodine fumarate extended-release tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Fesoterodine fumarate extended-release tablets is indicated for the treatment of neurogenic detrusor overactivity (NDO) in pediatric patients 6 years of age and older with a body weight greater than 25 kg.
- generic_name
- fesoterodine fumarate
- product_names
- FESOTERODINE FUMARATE
- ndc
- 72603-413, 72603-414, 72603-413-01, 72603-414-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en